BUDENID Steri Nebs susp inhal 1 mg/2ml 20 x 2 ml
7680600870031
CH-60087
R03BA02
03.04.4.
1 / 3
google
Details
- Product number
- 6008702
- CPT
- -
- Packaging group
- 20
- Unit
- Stück
- Composition
- budesonidum 0.5 mg, polysorbatum 80, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, dinatrii edetas, aqua ad iniectabile q.s. ad suspensionem pro 1 ml.
Articles (1)
Budenid Steri-Nebs 1mg/2ml, Suspension für einen Vernebler
suspension
20
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
budesonidum
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 60087
- Drug name
- Budenid Steri-Nebs, Suspension für einen Vernebler
- Galenic form
- SUVE
- ATC Code
- R03BA02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 08/07/2010
- Authorization expiration date
- 20/02/2026
- IT number
- 03.04.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BUDENID Steri Nebs susp inhal 1 mg/2ml 20 x 2 ml
- Description (DE)
- BUDENID Steri Nebs Inhal Susp 1 mg/2ml 20 x 2 ml
- Market launch
- 08/07/2010
- Market withdrawal
- 30/08/2025
- Narcotic (BTM)
- No